drugset / Trial / NCT06807866

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

NCT06807866

Phase 4 Recruiting 64 enrolled University of Miami
RandomizedParallel-groupDouble-blindSupportive care

Summary

The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.

Timeline

Start
2025-03-01
Primary completion
2026-12-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications

No indication recorded.